Ajeeta B Dash (Ajeeta Dash)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Acute Lymphoblastic Leukemia

Prognostic Factors

Chronic Kidney Disease

Multiple Myeloma

Top Venues

Blood cancer journal

European journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Juan José Lahuerta, Irene Manrique, Meletios A Dimopoulos, Francesca Gay, Chang-Ki Min, Sonja Zweegman, Ivan Spicka, Raphael Teipel, Maria-Victoria Mateos-Manteca, Nicola Giuliani, Michele Cavo, Christine Rojas, Weijun Fu, Kaveri Suryanarayan, Alexander Vorog, Cong Li, Bingxia Wang, Jose Estevam, Richard Labotka, Ajeeta B Dash
MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials. Blood (2022)
Kenneth C Anderson, Daniel Auclair, Stacey J Adam, Amit Agarwal, Melissa Anderson, Herve Avet-Loiseau, Mark Bustoros, Jessica R Chapman, Dana E Connors, Ajeeta B Dash, Alessandra Di Bacco, Ling Du, Thierry Facon, Juan A Flores-Montero, Francesca Gay, Irene M Ghobrial, Nicole J Gormley, Ira Gupta, Howard Higley, Jens Hillengass, Bindu Kanapuru, Dickran Kazandjian, Gary J Kelloff, Ilan R Kirsch, Brandon E Kremer, Carl Ola Landgren, Elizabeth D Lightbody, Oliver C Lomas, Sagar Lonial, Maria Victoria Mateos, Rocio Montes de Oca, Lata Mukundan, Nikhil C Munshi, Elizabeth K O'Donnell, Alberto Orfao, Bruno Paiva, Reshma Patel, Trevor J Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A Ross, Caroline C Sigman, Katie L Thoren, Suzanne Trudel, Gary A Ulaner, Nancy Valente, Brendan M Weiss, Elena Zamagni, Shaji K Kumar
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Ajeeta B Dash, Jacob Zhang, Lei Shen, Bin Li, Deborah Berg, Jianchang Lin, Hervé Avet-Loiseau, Nizar J Bahlis, Phillipe Moreau, Paul G Richardson, Alessandra Di Bacco
Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-κB pathway activation. European journal of haematology 105 (3) (2020)
Ronan T Swords, Steven Coutre, Michael B Maris, Joshua F Zeidner, James M Foran, Jose Cruz, Harry P Erba, Jesus G Berdeja, Wayne Tam, Saran Vardhanabhuti, Lwona Dobler, Hélène M Faessel, Ajeeta B Dash, Farhad Sedarati, Douglas V Faller, Michael R Savona
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML. Blood 131 (13) (2018)